EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer

Nazan Eras, Ferah Tuncel, Zuhal Altıntas, Sema Erden

Polish Journal of Pathology · 2024

DOI: 10.5114/pjp.2024.135703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Journal of Pathology, 2024. Verfasst von Nazan Eras und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Mersin University, Mersin, Turkey. Hauptthemen laut MEDLINE: BRCA1 Protein, BRCA2 Protein, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although BRCA genes are well-known breast cancer genes, the clinicopathological features of breast cancer patients carrying BRCA1/2 pathogenic variants have not been adequately defined. The goals of this study were to determine the distribution of BRCA1/2 variants in the Turkish population and its correlation with clinicopathological features.

Clinical data of 151 women who underwent BRCA1/2 gene testing at Mersin University Medical Faculty Hospital between 2016 and 2019 were retrospectively analyzed. BRCA1/2 variants were detected as pathogenic (n = 11), variants of uncertain significance (n = 5), likely benign (n = 3), and benign (n = 81) in breast cancer cases.

The BRCA1/2 pathogenic variant carriers had a higher histological grade, rate of triple- negative type, Ki-67 proliferation index, and rate of no special type carcinoma than the group without mutation (p = 0.03, 0.01, 0.04, and 0.02 respectively).

We analyzed the distribution of variants we detected in women living in our region and found that pathogenic variants in patients with breast cancer were associated with high histological grade, triple-negative type, high Ki-67 proliferation index, and histological type. Studies in diverse populations are needed to establish a clinicopathological relationship with variants more easily.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinBRCA2 ProteinBreast NeoplasmsHumansFemaleMiddle AgedAdultRetrospective StudiesGenetic Predisposition to DiseaseAgedTurkeyMutationBiomarkers, Tumor

Stichwörter der Autor:innen

Ki-67 proliferation indexbreast cancerhistological gradetriple-negative statusvariant.BRCA

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, Mersin University, Mersin, Turkey.
  • Department of Pathology, Faculty of Medicine, Mersin University, Mersin, Turkey.

Zitieren

APA

Eras, N., Tuncel, F., Altıntas, Z., & Erden, S. (2024). Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer. Polish Journal of Pathology. https://doi.org/10.5114/pjp.2024.135703

Vancouver

Eras N, Tuncel F, Altıntas Z, Erden S. Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer. Polish Journal of Pathology. 2024. doi:10.5114/pjp.2024.135703

BibTeX
@article{Eras2024,
  author = {Eras, Nazan and Tuncel, Ferah and Altıntas, Zuhal and Erden, Sema},
  title = {Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer},
  journal = {Polish Journal of Pathology},
  year = {2024},
  doi = {10.5114/pjp.2024.135703}
}
Kostenlos starten →